Alpha Tau Medical Ltd. - Ordinary Shares, no par value (DRTS)

Historical Holders from Q1 2022 to Q3 2025

Symbol
DRTS on Nasdaq
Type / Class
Equity / Ordinary Shares, no par value
Shares outstanding
86,723,804
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
1,832,497
Holdings value
$8,263,970
% of all portfolios
0%
Number of holders
31
Number of buys
16
Number of sells
-6
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Alpha Tau Medical Ltd. - Ordinary Shares, no par value (DRTS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ORAMED PHARMACEUTICALS INC. 20% $37,250,719 14,110,121 Oramed Pharmaceuticals Inc. 24 Apr 2025
Sofer Uzi 15.8% $42,751,366 13,702,361 Uzi Sofer 31 Dec 2022

Institutional Holders of Alpha Tau Medical Ltd. - Ordinary Shares, no par value (DRTS)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 1,832,497 $8,263,970 +$1,145,345 $4.51 31
2025 Q2 1,586,693 $4,950,874 +$1,313,729 $3.12 24
2025 Q1 1,172,124 $2,940,869 +$461,245 $2.51 23
2024 Q4 1,008,266 $3,125,497 +$134,426 $3.10 22
2024 Q3 948,076 $2,228,639 -$143,072 $2.38 23
2024 Q2 1,296,861 $3,253,557 -$1,298,641 $2.53 24
2024 Q1 1,827,730 $5,350,437 +$48,533 $2.95 27
2023 Q4 1,840,525 $5,505,585 +$2,478,553 $3.01 26
2023 Q3 975,005 $3,652,424 +$100,183 $3.79 23
2023 Q2 948,570 $4,107,472 +$2,064,199 $4.37 20
2023 Q1 652,086 $1,871,091 +$336,132 $2.87 16
2022 Q4 533,823 $1,697,581 -$889,137 $3.18 13
2022 Q3 697,266 $4,011,000 -$4,736 $5.84 16
2022 Q2 653,675 $5,920,000 +$1,784,957 $9.01 13
2022 Q1 447,472 $5,281,000 +$5,281,000 $11.81 11